EcoDrugPlus

Adrenoceptor Alpha 1a

Ensembl ID : ENSPKIG00000023699
Gene Symbol: ADRA1A
4 Cross references
200 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSPKIG00000018012
Gene Symbol: ADRA1B
3 Cross references
196 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSPKIG00000009231
Gene Symbol: ADRA1B
3 Cross references
191 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSPKIG00000011098
Gene Symbol: ADRA1D
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSPKIG00000017569
Gene Symbol: ADRA2A
1 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSPKIG00000004535
Gene Symbol: ADRA2C
1 Cross references
157 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSPKIG00000000297
Gene Symbol: ADRA2C
1 Cross references
160 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSPKIG00000010458
Gene Symbol: ADRB1
3 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSPKIG00000006595
Gene Symbol: ADRB2
3 Cross references
195 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSPKIG00000007256
Gene Symbol: ADRB3A
1 Cross references
196 Possible Orthologues:

Adrenoceptor Beta 3b

Ensembl ID : ENSPKIG00000020608
Gene Symbol: ADRB3B
1 Cross references
144 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSPKIG00000009077
Gene Symbol: LOC111859027
3 Cross references
297 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).